[Three cases of panniculitis due to Mycobacterium abscessus after mesotherapy].
Gutiérrez-de la Peña
J
J
Ruiz-Veramendi
M
M
Montis-Suau
A
A
Martín-Santiago
A
A
D000038:Abscess / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology / Q000601:surgery; D000328:Adult; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003357:Cosmetic Techniques / Q000009:adverse effects*; D004196:Disease Outbreaks; D004322:Drainage; D005260:Female; D006801:Humans; D007271:Injections, Intradermal / Q000009:adverse effects*; D008419:Materia Medica / Q000008:administration & dosage / Q000627:therapeutic use; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000601:surgery; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification* / Q000472:pathogenicity; D009894:Opportunistic Infections / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000382:microbiology; D015434:Panniculitis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000382:microbiology; D012883:Skin Ulcer / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D013030:Spain / Q000453:epidemiology; D014375:Tuberculoma / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D014946:Wound Infection / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D008419:Materia Medica; D000583:Amikacin; D017291:Clarithromycin